A novel compound heterozygous ROMK mutation presenting as late onset Bartter syndrome associated with nephrocalcinosis and elevated 1,25(OH)(2) vitamin D levels

作者：Sharma Amita^*; Linshaw Micheal A

来源：Clinical and Experimental Nephrology, 2011, 15(4): 572-576.

DOI：10.1007/s10157-011-0431-3

• Bartter syndrome
• Late presentation
• 1,25(OH)(2) vitamin D
• ROMK
• KCNJ1

Bartter syndrome (BS) is a rare renal tubular disorder presenting with hypokalemic metabolic alkalosis, which is classified into five types. KCNJ1 mutations usually cause the neonatal form of BS, type II BS (OMIM 241200). However, this report concerns a female patient with a novel, compound heterozygous KCNJ1 mutation that causes late-onset BS. The unique clinical findings of this case include persistently elevated 1,25(OH)(2) vitamin D levels, possibly due to increase prostaglandin E-2 levels, and medullary nephrocalcinosis. Treatment with COX-2 inhibitors resolved her hypercalciuria and improved her height and weight; renal function remains stable and there is no progression of nephrocalcinosis.

• 出版日期2011-8